Cas:890656-26-5 ethyl 3-amino-4-bromo-1H-pyrrole-2-carboxylate manufacturer & supplier

Chemical Name:ethyl 3-amino-4-bromo-1H-pyrrole-2-carboxylate

CAS.NO:890656-26-5

Synonyms:3-amino-4-bromo-1H-pyrrole-2-carboxylic acid ethyl ester;1H-Pyrrole-2-carboxylic acid,3-amino-4-bromo-,ethyl ester

Molecular Formula:C₇H₉BrN₂O₂

Molecular Weight:233.06300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:68.11000

Exact Mass:231.98500

LogP:2.11730

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-amino-4-bromo-1H-pyrrole-2-carboxylic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrrole-2-carboxylic acid,3-amino-4-bromo-,ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrrole-2-carboxylic acid,3-amino-4-bromo-,ethyl ester Use and application,3-amino-4-bromo-1H-pyrrole-2-carboxylic acid ethyl ester technical grade,usp/ep/jp grade.

Related News: In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers. 2-(4-methoxyphenyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid manufacturers Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. 4,4′-(1,4-phenylene)bis(2-amino-6,7-dihydro-5H-cyclopenta[b]pyridine-3-carbonitrile) suppliers developing a New Deal for post-graduate research students, starting later this year with a cross-sectoral consultation led by UKRI methyl 3-[carbamoyl(dimethylamino)amino]propanoate vendor & factory During Covid-19, the company has helped fill a void in meeting API demand for medicines used to treat patients with the virus. In April of last year, Wavelength expanded its production of API for three generic drugs— sedative midazolam, muscle relaxant cisatracurium, and paralytic rocuronium — to help keep up with hospital demand.,In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers.